Literature DB >> 18000863

Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.

Petra Willems1, Kathleen Claes, Ans Baeyens, Veerle Vandersickel, Joke Werbrouck, Kim De Ruyck, Bruce Poppe, Rudy Van den Broecke, Amin Makar, Emanuela Marras, Gianpaolo Perletti, Hubert Thierens, Anne Vral.   

Abstract

As enhanced chromosomal radiosensitivity (CRS) results from non- or misrepaired double strand breaks (DSBs) and is a hallmark for breast cancer and single nucleotide polymorphisms (SNPs) in DSB repair genes, such as non homologous end-joining (NHEJ) genes, could be involved in CRS and genetic predisposition to breast cancer. In this study, we investigated the association of five SNPs in three different NHEJ genes with breast cancer in a population-based case-control setting. The total patient population composed of a selected group of patients with a family history of the disease and an unselected group, consisting mainly of sporadic cases. SNP analysis showed that the c.2099-2408G>A SNP (XRCC5Ku80) [corrected] has a significant, positive odds ratio (OR) of 2.81 (95% confidence interval (CI): 1.30-6.05) for the heterozygous (He) and homozygous variant (HV) genotypes in the selected patient group. For the c.-1310 C>G SNP (XRCC6Ku70)[corrected] a significant OR of 1.85 (95%CI: 1.01-3.41) was found for the He genotype in the unselected patient group. On the contrary, the HV genotype of c.1781G>T (XRCC6Ku70) [corrected] displays a significant, negative OR of 0.43 (95%CI: 0.18-0.99) in the total patient population. The He+HV genotypes of the c.2099-2408G>A SNP (XRCC5Ku80) [corrected] also showed high and significant ORs in the group of "radiosensitive," familial breast cancer patients. In conclusion, our results provide preliminary evidence that the variant allele of c.-1310C>G (XRCC6Ku70) [corrected]and c.2099-2408G>A (XRCC5Ku80) [corrected] are risk alleles for breast cancer as well as CRS. The HV genotype of c.1781G>T (XRCC6Ku70) [corrected] on the contrary, seems to protect against breast cancer and ionizing radiation induced micronuclei. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18000863     DOI: 10.1002/gcc.20515

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

Review 1.  DNA repair dysregulation from cancer driver to therapeutic target.

Authors:  Nicola J Curtin
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

2.  Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.

Authors:  Hong Jiang; Yun Lin; Chang-qing Yang; Qi Li; Jinhong Luo; Ying Zhou; Junli Xue; Wei Wei; Yong Gao
Journal:  Tumour Biol       Date:  2012-12-28

3.  Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.

Authors:  Ming Yin; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Michael O'Reilly; Daniel Gomez; Minghuan Li; Ritsuko Komaki; Qingyi Wei
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

4.  The Ku70 -1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population.

Authors:  Wenshan He; Sijia Luo; Tao Huang; Jinghua Ren; Xiaoling Wu; Jun Shao; Qingyao Zhu
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

Review 5.  Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.

Authors:  Haitao Xu; Peng Zou; Pin Chen; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-08

6.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  Penelope Ae Main; Manya T Angley; Catherine E O'Doherty; Philip Thomas; Michael Fenech
Journal:  Nutr Metab (Lond)       Date:  2012-04-24       Impact factor: 4.169

Review 7.  Evaluating the effects of genetic variants of DNA repair genes using cytogenetic mutagen sensitivity approaches.

Authors:  Sherif Z Abdel-Rahman; Randa A El-Zein
Journal:  Biomarkers       Date:  2011-05-20       Impact factor: 2.658

8.  A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure.

Authors:  Petra Willems; Kim De Ruyck; Rudy Van den Broecke; Amin Makar; Gianpaolo Perletti; Hubert Thierens; Anne Vral
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-15       Impact factor: 4.553

9.  Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage.

Authors:  Katja Goricar; Nina Erculj; Maja Zadel; Vita Dolzan
Journal:  Radiol Oncol       Date:  2012-01-02       Impact factor: 2.991

10.  Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment.

Authors:  C Badie; S Dziwura; C Raffy; T Tsigani; G Alsbeih; J Moody; P Finnon; E Levine; D Scott; S Bouffler
Journal:  Br J Cancer       Date:  2008-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.